Based in Francisco Akiri It is a healthcare startup that utilizes Blockchain Create a cloud-based invitation-only trust network for sharing healthcare data. Akiri recently received a $ 10 million investment from Health2047, American Medical Association (AMA).Akiri’s network and brand Akiri SwitchIs their proposed solution to the medical and financial problems currently rising in the medical sector due to medical data that remains “silo-trapped”.
Akiri Switch Is a cloud-based trust network for sharing medical data. The Akiri team strongly emphasizes that Akiri Switch is not a health information exchange (HIE). There is also no extract-transform-load (ETL) system. again, Electronic health record ((((EHR). Rather, Akiri Switch is a “software-defined networking (SDN) and secure routing protocol” for transmitting health, wellness, and medical data. Akiri Switch does not store healthcare information, it only sends information from a trusted subscriber to another subscriber using blockchain technology for secure transmission. The Akiri team claims that their network has built-in support for a wide range of features essential to a robust and efficient trusted network. These features span security and compliance. Identification and authentication; Analysis and application support. According to the Akiri team, the Akiri Switch network is vendor-independent and has the flexibility to send medical data between medical companies with completely different database systems or “silo”.
To illustrate the scope of the solution, the Akiri team claims that the trust network provides something to all the key participants in the modern medical ecosystem. Patients are more reassured that they know that medical data will be securely transmitted over a network of trusted partners. Physicians improve access to safe and reliable medical data. Providers can benefit from a significantly simplified and streamlined IT infrastructure. Payers can enjoy the reduction in IT development costs. Pharmaceutical companies will find it easier to comply with regulatory controls. Developers have the opportunity to leverage Akiri’s open development platform to build innovative healthcare solutions.
Akiri Switch is available by invitation as a subscriber-based service. The first subscriber to Akiri Switch is AMA, the largest medical association in the United States with over 200,000 members. Dr. James L. Madera, CEO of AMA maintain The current data liquidity issue that Akiri Switch aims to help resolve is that it is “one of the biggest barriers to improving patient-doctor relationships.” In addition to the first subscriber (AMA), Akiri also attracted the first partner collaborators. CelgeneA major biopharmacy company focused primarily on cancer treatment.
team
The Akiri team previously includes talent from GE Healthcare, Stanford, Apple, Cisco, and other major healthcare and IT organizations. CEO Dr. Adriaan Ligtenberg is also an advisory board to Health 2047. His career includes IT, healthcare and investment, worked at Bell Labs, taught at Princeton University, and founded several successful Silicon Valley startups. COO Daphne Li, MBA, is also Director of Business Acceleration at Health 2047 and has previously held prominent positions at Apple and ADP after earning an MBA in Economics from Stanford University. The six-member team also includes a former director of Stanford Health Care, a former engineering president of GE Healthcare, and a former senior director of software development at Cisco DNA Center.
Funding and mission
January 3, Akiri announcement $ 10 Million Series A Investment from Health2047, Received a founding investment from AMA. Formerly Health 2047 SwitchCo, Akiri is “the first spin-out of Health 2047.” Based in Silicon Valley, Health 2047 describes itself as an “innovation company.” Health2047’s mission is to create a systematic solution to long-standing medical problems to achieve secure medical data mobility with the help of AMA. A healthcare model focused on chronic care. The “fundamental productivity” of the entire healthcare ecosystem. Value-based medical transactions.
